文献速递手外科与足踝外科骨质疏松与代谢性骨病

36种手与腕疾病-治疗组合中四种常用患者报告结局指标的最小重要变化值是多少

What Are the Minimally Important Changes of Four Commonly Used Patient-reported Outcome Measures for 36 Hand and Wrist Condition-Treatment Combinations?
PubMed 文献 · Clin Orthop Relat Res · 2021-12-27

该研究基于荷兰26家门诊2013年11月至2020年11月的纵向数据库,纳入23 749例患者、36种疾病-治疗组合,采用两种锚定法估算四种PROM的最小重要变化值(MIC)。结果显示MIC随疾病-治疗组合及治疗侵入性而异,非手术治疗组的MIC低于手术组(p < 0.001)。

要点

  • MIC因疾病-治疗组合不同而差异较大,具有情境特异性。
  • 非手术治疗组的MIC低于手术组(p < 0.001)。
  • 非手术MIC约量表九分之一(约100分制11分),手术约五分之一(约19分)。

核心结论

  • MIC在不同疾病-治疗组合间存在差异,并因干预的侵入性不同而不同。
  • 接受更具侵入性治疗的患者治疗期望更高、可能承受更多不适或认为应获得更大改善,从而对有益治疗效应的感知不同。

研究设计与样本

  • 基于荷兰26家门诊2013年11月至2020年11月纵向维护数据库的队列数据。
  • 数据库含55 651例患者,排除仅需诊断处理1528例、未完成治疗结果满意度问卷25 099例、基线或随访时目标PROM缺失3509例、疾病-治疗组合不足100例的1766例。
  • 最终样本23 749例(占全部43%),含36种疾病-治疗组合;非手术治疗6179例(26%),手术治疗17 570例(74%);平均年龄55±14岁,女性15 593例(66%)。
  • 采用锚定平均变化法和MIC预测法两种锚定法估算MIC,随后三角化获得单一MIC。
  • 非手术及小手术(含扳机指松解)最终随访为3个月,大手术(如大多角骨切除)为12个月。

主要发现

  • 三角化MIC在疾病-治疗组合间变异很大,如手骨关节炎非手术治疗负荷时VAS疼痛MIC聚集在10(四分位距8至11),腕截骨/腕骨切除约25(IQR 24至27),神经减压为21。
  • MHQ总分MIC从4(CMC1骨关节炎非手术治疗)到15(大多角骨切除联合LRTI及骨隧道)。
  • PRWHE总分MIC从2(STT骨关节炎非手术治疗)到29(第一伸肌间室松解)。
  • BCTQ症状严重度量表MIC从0.44(腕管综合征非手术治疗)到0.87(腕管松解)。
  • 合并治疗组中非手术治疗MIC低于手术治疗(p < 0.001);非手术MIC约量表九分之一(IQR 0.08至0.13,约100分制11分),手术约五分之一(IQR 0.14至0.24,约100分制19分)。

关键数值与推荐

  • 手骨关节炎非手术治疗负荷时VAS疼痛MIC约10(IQR 8至11)。
  • 腕截骨/腕骨切除VAS疼痛MIC约25(IQR 24至27),神经减压为21。
  • MHQ总分MIC范围4(CMC1骨关节炎非手术治疗)至15(大多角骨切除联合LRTI及骨隧道)。
  • PRWHE总分MIC范围2(STT骨关节炎非手术治疗)至29(第一伸肌间室松解)。
  • BCTQ症状严重度量表MIC范围0.44(腕管综合征非手术治疗)至0.87(腕管松解)。

临床怎么用

  • 作者认为MIC具有情境特异性,不当应用可能产生误导。
  • 作者认为在临床研究中实施这些疾病和治疗特异性MIC有助于更好的研究设计和更准确的治疗评估。
  • 作者认为这有助于临床医生更好地告知患者预期治疗结果并促进共享决策。
  • 作者提出未来研究可关注自适应技术以实现个体化MIC。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient-reported outcome measures (PROMs) are frequently used to assess treatment outcomes for hand and wrist conditions. To adequately interpret these outcomes, it is important to determine whether a statistically significant change is also clinically relevant. For this purpose, the minimally important change (MIC) was developed, representing the minimal within-person change in outcome that patients perceive as a beneficial treatment effect. Prior studies demonstrated substantial differences in MICs between condition-treatment combinations, suggesting that MICs are context-specific and cannot be reliably generalized. Hence, a study providing MICs for a wide diversity of condition-treatment combinations for hand and wrist conditions will contribute to more accurate treatment evaluations. QUESTIONS/PURPOSES: (1) What are the MICs of the most frequently used PROMs for common condition-treatment combinations of hand and wrist conditions? (2) Do MICs vary based on the invasiveness of the treatment (nonsurgical treatment or surgical treatment)? METHODS: This study is based on data from a longitudinally maintained database of patients with hand and wrist conditions treated in one of 26 outpatient clinics in the Netherlands between November 2013 and November 2020. Patients were invited to complete several validated PROMs before treatment and at final follow-up. All patients were invited to complete the VAS for pain and hand function. Depending on the condition, patients were also invited to complete the Michigan Hand outcomes Questionnaire (MHQ) (finger and thumb conditions), the Patient-rated Wrist/Hand Evaluation (PRWHE) (wrist conditions), or the Boston Carpal Tunnel Questionnaire (BCTQ) (nerve conditions). Additionally, patients completed the validated Satisfaction with Treatment Result Questionnaire at final follow-up. Final follow-up timepoints were 3 months for nonsurgical and minor surgical treatment (including trigger finger release) and 12 months for major surgical treatment (such as trapeziectomy). Our database included 55,651 patients, of whom we excluded 1528 who only required diagnostic management, 25,099 patients who did not complete the Satisfaction with Treatment Result Questionnaire, 3509 patients with missing data in the PROM of interest at baseline or follow-up, and 1766 patients who were part of condition-treatment combinations with less than 100 patients. The final sample represented 43% (23,749) of all patients and consisted of 36 condition-treatment combinations. In this final sample, 26% (6179) of patients were managed nonsurgically and 74% (17,570) were managed surgically. Patients had a mean ± SD age of 55 ± 14 years, and 66% (15,593) of patients were women. To estimate the MIC, we used two anchor-based methods (the anchor mean change and the MIC predict method), which were triangulated afterward to obtain a single MIC. Applying this method, we calculated the MIC for 36 condition-treatment combinations, comprising 22 different conditions, and calculated the MIC for combined nonsurgical and surgical treatment groups. To examine whether the MIC differs between nonsurgical and surgical treatments, we performed a Wilcoxon signed rank test to compare the MICs of all PROM scores between nonsurgical and surgical treatment. RESULTS: We found a large variation in triangulated MICs between the condition-treatment combinations. For example, for nonsurgical treatment of hand OA, the MICs of VAS pain during load clustered around 10 (interquartile range 8 to 11), for wrist osteotomy/carpectomy it was around 25 (IQR 24 to 27), and for nerve decompression it was 21. Additionally, the MICs of the MHQ total score ranged from 4 (nonsurgical treatment of CMC1 OA) to 15 (trapeziectomy with LRTI and bone tunnel), for the PRWHE total score it ranged from 2 (nonsurgical treatment of STT OA) to 29 (release of first extensor compartment), and for the BCTQ Symptom Severity Scale it ranged from 0.44 (nonsurgical treatment of carpal tunnel syndrome) to 0.87 (carpal tunnel release). An overview of all MIC values is available in a freely available online application at: https://analyse.equipezorgbedrijven.nl/shiny/mic-per-treatment/. In the combined treatment groups, the triangulated MIC values were lower for nonsurgical treatment than for surgical treatment (p < 0.001). The MICs for nonsurgical treatment can be approximated to be one-ninth (IQR 0.08 to 0.13) of the scale (approximately 11 on a 100-point instrument), and surgical treatment had MICs that were approximately one-fifth (IQR 0.14 to 0.24) of the scale (approximately 19 on a 100-point instrument). CONCLUSION: MICs vary between condition-treatment combinations and differ depending on the invasiveness of the intervention. Patients receiving a more invasive treatment have higher treatment expectations, may experience more discomfort from their treatment, or may feel that the investment of undergoing a more invasive treatment should yield greater improvement, leading to a different perception of what constitutes a beneficial treatment effect. CLINICAL RELEVANCE: Our findings indicate that the MIC is context-specific and may be misleading if applied inappropriately. Implementation of these condition-specific and treatment-specific MICs in clinical research allows for a better study design and to achieve more accurate treatment evaluations. Consequently, this could aid clinicians in better informing patients about the expected treatment results and facilitate shared decision-making in clinical practice. Future studies may focus on adaptive techniques to achieve individualized MICs, which may ultimately aid clinicians in selecting the optimal treatment for individual patients.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Hoogendam L, Koopman JE, van Kooij YE, et al. What Are the Minimally Important Changes of Four Commonly Used Patient-reported Outcome Measures for 36 Hand and Wrist Condition-Treatment Combinations? Clin Orthop Relat Res. 2021. PMID: 34962496. doi:10.1097/CORR.0000000000002094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。